N/A
|
GBT 440（Cat No.:I001717）, also known as Voxelotor, is an oral therapy designed to treat sickle cell disease (SCD) by increasing hemoglobin's affinity for oxygen, thereby preventing the polymerization of sickled red blood cells. By stabilizing
|
Buy from Supplier |
90
|
Voxar Inc
voxel atlas rating approach Voxel Atlas Rating Approach, supplied by Voxar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/voxel+analysis+suite+%28voxa%29/pmc04686005-103-4-8?v=Voxar+Inc Average 90 stars, based on 1 article reviews
voxel atlas rating approach - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
86
|
Skyscan Corporation
ct voxel “ ct vox software Ct Voxel “ Ct Vox Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/voxel+analysis+suite+%28voxa%29/pm30761901__nl8b04148_si_001-80-16-12?v=Skyscan+Corporation Average 86 stars, based on 1 article reviews
ct voxel “ ct vox software - by Bioz Stars,
2026-08
86/100 stars
|
Buy from Supplier |
N/A
|
This active molecular is a selective norepinephrine reuptake inhibitor that developed for ADHD (attention-deficit hyperactivity disorder) and as an antidepressant agent originated by Eli Lilly. In Jan 2014, Eli Lilly completed a phase III extension
|
Buy from Supplier |
N/A
|
Ravoxertinib (GDC-0994) is an orally active ERK kinase inhibitor with an IC50 of 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively.
|
Buy from Supplier |
N/A
|
GDC-0994 (Cat.No:I001753) is a small-molecule inhibitor used in cancer research. It targets the mitogen-activated protein kinase kinase 1 (MEK1) enzyme, which plays a critical role in cell growth and proliferation pathways. GDC-0994 has shown potential
|
Buy from Supplier |